Leukemia Posts Page 2 on Medivizor
Navigation Menu

Leukemia Posts on Medivizor

Drug interactions with tyrosine kinase inhibitors in chronic myeloid leukemia

Posted by on Jul 17, 2018 in Leukemia | 0 comments

In a nutshell This study investigated the interactions between tyrosine kinase inhibitors and other drugs taken at the same time in patients with chronic myeloid leukemia. This study concluded that drug interactions were found in a significant number of patients, with mild side effects. Some background Imatinib (Gleevec) and similar drugs are the...

Read More

A comparison of two different types of transplant therapy to treat acute myeloid leukemia

Posted by on Jul 15, 2018 in Leukemia | 0 comments

In a nutshell This study compared two different transplant therapies used to treat acute myeloid leukaemia (AML), unmanipulated haploidentical stem cell treatment (Haplo-SCT) and HLA-matched unrelated donor stem cell transplantation (MUD). The study found that both options are useful in treating AML but MUD may have increased risk of graft versus host...

Read More

A comparison of two different types of transplant therapy to treat acute myeloid leukemia

Posted by on Jul 15, 2018 in Leukemia | 0 comments

In a nutshell This study compared two different transplant therapies used to treat acute myeloid leukaemia (AML), unmanipulated haploidentical stem cell treatment (Haplo-SCT) and HLA-matched unrelated donor stem cell transplantation (MUD). The study found that both options are useful in treating AML but MUD may have increased risk of graft versus host...

Read More

Is there a link between recovery time for healthy white blood cells and infections in children with AML?

Posted by on Jul 15, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the effect of neutrophil recovery time (NRT – the return of white blood cells after treatment, that fight infection) on infections and relapse (return of disease) in children with acute myeloid leukaemia (AML). The study found that longer NRT was linked with increased risk of severe infections and relapse after...

Read More

Is there a link between recovery time for healthy white blood cells and infections in children with AML?

Posted by on Jul 15, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the effect of neutrophil recovery time (NRT – the return of white blood cells after treatment, that fight infection) on infections and relapse (return of disease) in children with acute myeloid leukaemia (AML). The study found that longer NRT was linked with increased risk of severe infections and relapse after...

Read More

Does risk level affect outcome of transplant treatments in acute myeloid leukemia?

Posted by on Jul 15, 2018 in Leukemia | 0 comments

In a nutshell This study compared two stem cell therapies called unmanipulated haploidentical and matched sibling donor transplant in the treatment of acute myeloid leukemia (AML).  The study concluded that matched sibling donor transplant was more effective in the treatment of AML. Some background AML is a cancer of the white blood cells in...

Read More

Transplant as a treatment for chronic lymphocytic patients who have progressed to Richter syndrome

Posted by on Jul 14, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if allogeneic hematopoietic cell transplantation is effective in patients who have progressed from chronic lymphocytic leukemia to Richter syndrome. This study concluded that allogeneic hematopoietic cell transplant is effective for these patients if they had an objective response before...

Read More

Does graft versus host disease affect relapse and survival rates after a stem cell transplant in childhood leukemia?

Posted by on Jul 13, 2018 in Leukemia | 0 comments

In a nutshell This study examined the effect of graft versus host disease on relapse rates in children with acute leukemia. This study concluded that graft versus host disease may protect against relapse, but they did not see an effect on survival. Some background One complication following an allogeneic stem cell transplant (transplant using donor...

Read More

ALL treatment in patients with Down syndrome

Posted by on Jul 13, 2018 in Leukemia | 0 comments

In a nutshell This study compared the safety and effectiveness of using the same treatment protocol in patients with Acute Lymphoblastic Leukemia (ALL) and Down’s Syndrome (DS) compared to patients with ALL without Down’s Syndrome. The study found that treatment for ALL was effective in both DS and non-DS patients but with more side effects...

Read More